buyers will wait till July too risky with IRWD already approved.
The Fly On The Wall
Synergy Pharmaceuticals price target raised to $19 from $11 at Canaccord. Canaccord raised its price target on Synergy Pharmaceuticals to $19 from $11 following positive top-line results from its Phase 3 trial for plecanatide in chronic idiopathic constipation.
good link right on The Fly
Sentiment: Strong Buy
$70's coming soon.
lock and loaded- make money
Adam F Tweet
Adam Feuerstein @adamfeuerstein $XON: “We’re pleased to distribute shares of over-inflated $ZIOPtoour shareholders. Sell them as fast as you can.”5 retweets 10 favorites